Side-effects and complications of foam sclerotherapy of the great and small saphenous veins: A controlled multicentre prospective study including 1025 patients

Phlebology

Volumn 24, Issue 3, 2009, Pages 131-138

  Gillet, J L ^a,c   Guedes, J M ^a   Guex, J J ^a   Hamel Desnos, C ^a   Schadeck, M ^a   Lauseker, M ^a   Allaert, F A ^b  

^a CHU du Bocage ^*  (France)

^b HÔPITAL DU BOCAGE   (France)

^c Vascular Medicine Phlebology   (France)

Author keywords

Complication; Foam sclerotherapy; Side effect; Venous insufficiency

Indexed keywords

POLIDOCANOL;

ADULT; AGED; ARTICLE; BLURRED VISION; CEREBROVASCULAR ACCIDENT; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; DEEP VEIN THROMBOSIS; ECHOGRAPHY; FEMALE; FOAM SCLEROTHERAPY; HUMAN; INCIDENCE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MULTICENTER STUDY; OUTCOME ASSESSMENT; OUTPATIENT DEPARTMENT; PATIENT ASSESSMENT; PHLEBOLOGY; PRESSURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SAMPLE; SAPHENOUS VEIN; SCLEROTHERAPY; SCOTOMA; SEPTICEMIA; THORAX; VEIN INSUFFICIENCY; VEIN OCCLUSION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; PROSPECTIVE STUDIES; SAPHENOUS VEIN; SCLEROTHERAPY; STROKE; VENOUS INSUFFICIENCY; VISION DISORDERS; YOUNG ADULT;

EID: 67549127335     PISSN: 02683555     EISSN: 14333031     Source Type: Journal    
DOI: 10.1258/phleb.2008.008063     Document Type: Article

References (58)

1. Cavezzi A, Frullini A, Ricci S, Tessari L. Treatment of varicose veins by foam sclerotherapy: two clinical series. Phlebology 2002;17:13-18 (Pubitemid 35231053)
2. Belcaro GM, Cesarone MR, Nicolaides AN, et al. Foam-sclerotherapy, surgery, sclerotherapy, and combined treatment for varicose veins: a 10-year, prospective, randomized, controlled, trial (VEDICO trial). Angiology 2003;54:307-315 (Pubitemid 36578462)
3. Hamel-Desnos C, Desnos P, Wollmann JC, Ouvry P, Mako S, Allaert FA. Evaluation of the efficacy of polidocanol in the form of foam compared with liquid form in sclerotherapy of the greater saphenous vein: initial results. Dermatol Surg 2003;29:1170-1175 (Pubitemid 38009913)
4. Yamaki T, Nozaki M, Iwasaka S. Comparative study of duplex-guided foam sclerotherapy and duplex-guided liquid sclerotherapy for the treatment of superficial venous insufficiency. Dermatol Surg 2004;30:718-722 (Pubitemid 38657962)
5. Barrett JM, Allen B, Ockelford A, Goldman MP. Micro-foam ultrasound-guided sclerotherapy of varicose veins in 100 legs. Dermatol Surg 2004;30:6-12 (Pubitemid 38174021)
6. Schadeck M. Sclérose de la petite veine saphène: comment éviter les mauvais résultats? Phlébologie 2004;57:165-169
7. Bountouroglou DG, Azzam M, Kakkos SK, Pathmarajah M, Young P, Geroulakos G. Ultrasound-guided foam sclerotherapy combined with sapheno-femoral ligation compared to surgical treatment of varicose veins: early results of a randomised controlled trial. Eur J Vasc Endovasc Surg 2006;31:93-100 (Pubitemid 43024990)
8. Wright D, Gobin JP, Bradbury AW, et al. on behalf of the European phase III investigators group. Varisolve® polidocanol microfoam compared with surgery or sclerotherapy in management of varicose veins in the presence of trunk vein incompetence: European randomized controlled trial. Phlebology 2006;21:180-190
9. Coleridge Smith P. Chronic venous disease treated by ultrasound guided foam sclerotherapy. Eur J Vasc Endovasc Surg 2006;32:577-583 (Pubitemid 44499463)
10. Bergan J, Pascarella L, Mekenas L. Venous disorders: treatment with sclerosant foam. J Cardiovasc Surg 2006;47:9-18
11. Sica M, Biasi G, George E. Méthode simplifiée d'injection endoveineuse de micromousse de Trombovar® à 1% par cathéter court (Méthode MS): une efficacité durable confirmée par les résultats à 2 ans. Phlébologie 2006;59:339-342
12. Ferrara F, Bernbach HR. Les résultats de la sclé rothérapie: suivi de 1000 crosses de la grande veine saphène à 10 ans. Phlébologie 2006;59:77-83
13. Ceulen RP, Bullens-Goessens YI, Pi-Van De Venne SJ, Nelemans PJ, Veraart JC, Sommer A. Outcomes and side effects of duplex-guided sclerotherapy in the treatment of great saphenous veins with 1% versus 3% polidocanol foam: results of a randomized controlled trial with one-year follow-up. Dermatol Surg 2007;33:276-281 (Pubitemid 46328226)
14. Hamel-Desnos C, Ouvry P, Benigni JP, et al. Comparison of 1% and 3% polidocanol foam in ultrasound guided sclerotherapy of the great saphenous vein: a randomised, double-blind trial with two year-follow-up. 'The 3/1 Study'. Eur J Vasc Endovasc Surg 2007;34:723-729
15. Jia X, Mowatt G, Burr JM, Cassar K, Cook J, Fraser C. Systematic review of foam sclerotherapy for varicose veins. BJS 2007;94:925-936 (Pubitemid 47236534)
16. Rabe E, Otto J, Schliephake D, Pannier F. Efficacy and safety of great saphenous vein sclerotherapy using standardised polidocanol foam (ESAF): a randomised controlled multicentre clinical trial. Eur J Vasc Endovasc Surg 2008;35:238-245 (Pubitemid 351163086)
17. Ouvry P, Allaert FA, Desnos P, Hamel-Desnos C. Efficacy of polidocanol foam versus liquid in sclerotherapy of the great saphenous vein: a multicentre randomised controlled trial with a two-year follow-up. EJVES 2008;36:366-370
18. Tessari L, Cavezzi A, Frullini A. Preliminary experience with a new sclerosing foam in the treatment of varicose veins. Dermatol Surg 2001;27:58-60 (Pubitemid 32107620)
19. Frullini A, Cavezzi A. Sclerosing foam in the treatment of varicose veins and telangiectases: history and analysis of safety and complications. Dermatol Surg 2002;28:11-15 (Pubitemid 34101573)
20. Varcoe PF. Ultrasound guided sclerotherapy: efficacy, adverse effects and dosing. An international survey. Aust N Z J Phlebol 2003;7:17-24
21. Benigni JP, Ratinahirana H. Mousse de polidocaol et migraine à aura. Phlébologie 2003;56:289-291
22. Barrett JM, Allen B, Ockelford A, Goldman MP. Microfoam ultrasound-guided sclerotherapy of varicose veins in 100 legs. Dermatol Surg 2004;30:6-12 (Pubitemid 38174021)
23. Barrett JM, Allen B, Ockelford A, Goldman MP. Microfoam ultrasound-guided sclerotherapy treatment for varicose veins in a subgroup with diameters at the junction of 10 mm or greater compared with a subgroup of less than 10 mm. Dermatol Surg 2004;30:1386-1390 (Pubitemid 39552228)
24. Guex J-J, Allaert FA, Gillet J-L, Chleir F. Immediate and mid-term complications of sclerotherapy. Report of a prospective multicentric registry of 12,173 sclerotherapy sessions. Dermatol Surg 2005;31:123-128
25. Alòs J, Carreño P, López JA, Estadella B, Serra-Prat M, Marinel-Lo J. Efficacy and safety of sclerotherapy using polidocanol foam: a controlled clinical trial. Eur J Vasc Endovasc Surg 2006;31:101-107 (Pubitemid 43024991)
26. Forlee MV, Grouden M, Moore DJ, Shanik G. Stroke after varicose vein foam injection sclerotherapy. J Vasc Surg 2006;43:162-164 (Pubitemid 43083525)
27. Smith PC. Chronic venous disease treated by ultrasound guided foam sclerotherapy. Eur J Vasc Endovasc Surg 2006;32:577-583 (Pubitemid 44499463)
28. Goldman PM, Bergan JJ, Guex JJ. Complications and Adverse Sequelae of Sclerotherapy, in Sclerotherapy, Treatment of Varicose and Telangiectatic Leg Veins. 4th edn, Mosby Elsevier, 2007:189-244
29. Myers KA, Jolley D, Clough A, Kirwan J. Outcome of ultrasound-guided sclerotherapy for varicose veins: medium-term results assessed by ultrasound surveillance. Eur J Vasc Endovasc Surg 2007;33:116-121 (Pubitemid 44872674)
30. Munavalli GS, Weiss RA. Complications of sclerotherapy. Semin Cutan Med Surg 2007;26:22-28 (Pubitemid 46349784)
31. Morrison N, Neuhardt DL, Rogers CR, et al. Comparisons of side effects using air and carbon dioxide foam for endovenous chemical ablation. J Vasc Surg 2008;47:830-836
32. Bush RG, Derrick M, Manjoney D. Major neurological events following foam sclerotherapy. Phlebology 2008;23:189-192
33. Ceulen RP, Sommer A, Vernooy K. Microembolism during foam sclerotherapy of varicose veins. N Engl J Med 2008;358:1525-1526
34. Cappelli M, Molino Lova R, Ermini S, Ganglands I, Giannelli F, Zamboni P. Haemodynamics of the saphenofemoral complex: an operational diagnosis of proximal femoral valve function. Int Angiol 2006;25:356-360 (Pubitemid 46350992)
35. Porter JM, Moneta GL, et al. International Consensus Committee on Chronic Venous Disease. Reporting standards in venous disease: an update. J Vasc Surg 1995;27:635-645
36. Eklöf B, Rutherford RB, Bergan JJ, et al. and the American Venous Forum International Ad Hoc Committee for Revision of the CEAP Classification. Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg 2004;40:1248-1252
37. Breu FX, Guggenbichler S, Wollmann JC. Second European Consensus Meeting on Foam Sclerotherapy. Duplex ultrasound and efficacy criteria in foam sclerotherapy from the 2nd European Consensus Meeting on Foam Sclerotherapy 2006, Tegernsee, Germany. 2008;37:90-95
38. Natali J, Farman T. Implications medico-légales au cours du traitement sclérothérapique des varices. J Mal Vasc 1996;21:227-232
39. Hanisch F, Müller T, Krivocuca M, Winterholler M. Stroke following variceal sclerotherapy. Eur J Med Res 2004;9:282-284
40. Meier B, Lock JE. Contemporary management of patent foramen ovale. Circulation 2003;107:5-9 (Pubitemid 36070923)
41. Morrison N, Cavezzi A, Bergan J, Partsch H. Letter to the editor regarding 'Stroke after varicose vein foam injection sclerotherapy'. J Vasc Surg 2007;44:224-225
42. Cabrera J, Cabrera J Jr, Garcia-Olmedo MA, Redondo P. Treatment of venous malformations with sclerosant in microfoam form. Arch Dermatol 2003;139:1409-1416 (Pubitemid 37433130)
43. Hill D, Hamilton R, Fung T. Assessment of techniques to reduce sclerosant foam migration during ultrasound-guided sclerotherapy of the Great Saphenous vein. J Vasc Surg 2008;48:934-939
44. Künzlberger B, Pieck C, Altmeyer P, Stücker M. Migraine ophthalmique with reversible scotomas after sclerotherapy with liquid 1% polidocanol. Dermatol Surg 2006;32:1410-1413 (Pubitemid 44691149)
45. Dowson A, Mullen MJ, Peatfield R, et al. Migraine Intervention with STARFlex Technology (MIST) trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation 2008;117:1397-1404
46. Hamel-Desnos C, Guias B, Quéhé P, et al. Foam sclerotherapy of saphenous veins with or without medical support stocking (compression) - Biological effects of foam sclerotherapy - Randomized study [abstract]. Ninth Annual Meeting of the European Venous Forum, 26-28 June 2008, Barcelona
47. Gillet J-L, Perrin M, Cayman R. Thromboses veineuses superficielles des membres inférieurs. Etude prospective portant sur 100 patients. J Mal Vasc 2001;1:16-22 (Pubitemid 32209771)
48. MacDonald PS, Kahn SR, Miller N, Obrand D. Shortterm natural history of isolated gastrocnemius and soleal vein thrombosis. J Vasc Surg 2003;37:523-527 (Pubitemid 36350893)
49. Gillet JL, Perrin M, Allaert FA. Short and mid-term outcome of isolated symptomatic muscular calf vein thrombosis. J Vasc Surg 2007;46:513-519 (Pubitemid 47371061)
50. van Rij AM, Chai J, Hill GB, Christie RA. Incidence of deep vein thrombosis after varicose vein surgery. Br J Surg 2004;91:1582-1585 (Pubitemid 39619921)
51. Weiss RA, Weiss MA. Controlled radiofrequency endovenous occlusion using a unique radiofrequency catheter under duplex guidance to eliminate saphenous varicose vein reflux: a two-year follow-up. Dermatol Surg 2002;28:38-42 (Pubitemid 34101579)
52. Kistner RL. Endovascular obliteration of the greater saphenous vein: the Closure procedure. Jpn J Phlebol 2002;13:325-333
53. Hingorani AP, Ascher E, Markevich N, et al. Deep venous thrombosis after radiofrequency ablation of greater saphenous vein: a word of caution. J Vasc Surg 2004;40:500-504 (Pubitemid 39165026)
54. Merchant RF, Pichot O, Myers KA. Four-year follow-up on endovascular radiofrequency obliteration of great saphenous reflux. Dermatol Surg 2005;31:129-134 (Pubitemid 40990936)
55. Min RJ, Zimmet SE, Isaacs MN, Forrestal MD. Endovenous laser treatment of the incompetent greater saphenous vein. J Vasc Interv Radiol 2001;12:1167-1171 (Pubitemid 32983353)
56. Anastasie B, Celerier A, Cohen-Solal G, Anido R, Mordon S, et al. Laser endoveineux. Phlébologie 2003; 56:369-382
57. Proebstle TM, Gül D, Kargl A, Knop J. Endovenous laser treatment of the lesser saphenous vein with a 940-nm diode laser: early results. Dermatol Surg 2003;29:357-361 (Pubitemid 36417448)
58. Mozes G, Kalra M, Carmo M, Swenson L, Gloviczki P. Extension of saphenous thrombus into the femoral vein: a potential complication of new endovenous ablation techniques. J Vasc Surg 2005;41:130-135 (Pubitemid 40193350)